SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Index: Clinical Trials

index 1,719 words KG: CLINICAL TRIALS 2026-03-24

kind:index section:clinical-trials

Contents

Clinical Trials

Knowledge Graph

Related Hypotheses (30)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Closed-loop transcranial focused ultrasound to restore hippo
Score: 0.71 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.70 TREM2-Dependent Microglial Senescence Transition
Score: 0.69

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph
Score: 0.61 APOE-Dependent Autophagy Restoration
Score: 0.61 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli
Score: 0.60 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Context-Dependent Cx43 Modulation Based on Disease Stage
Score: 0.58 Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Blood-Brain Barrier SPM Shuttle System
Score: 0.55 TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S
Score: 0.55 Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55 Retinal Vascular Microcirculation Rescue
Score: 0.54 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 NLRP3/Mitophagy Coupling Modulation
Score: 0.52 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.51 P2RX7-Mediated Exosome Secretion Blockade
Score: 0.51 Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.51 SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51 Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.50

Related Analyses (23)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed How can subcellular compartmentalization defects be measured
neuroscience · failed Do stellate neurons express unique α7 nicotinic receptor sub
neurodegeneration · failed

Why have numerous phase 3 clinical trials failed despite adv
neurodegeneration · completed Why have anti-Aβ clinical trials failed despite the establis
neurodegeneration · failed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (30)

s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40 s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40 Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40

Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40 Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40 Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40 Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.40 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40 C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Environmental Exposure Causal Attribution in ALS — Experimen
validation · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio
validation · proposed · Score: 0.40 Iron Dyshomeostasis in MSA Pathogenesis Experiment
validation · proposed · Score: 0.40 AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.40 Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40 Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40 Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.40 N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper
clinical · proposed · Score: 0.40

SciDEX — scidex.ai — Dashboard | Atlas